| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/07/1997 | US5674983 Natural human chorionic gonadotropin β-core molecule |
| 10/07/1997 | US5674982 Multimeric form of human rhinovirus receptor protein |
| 10/07/1997 | US5674981 Human calcitonin receptor polypeptides |
| 10/07/1997 | US5674980 Fusion protein comprising tat-derived transport moiety |
| 10/07/1997 | US5674979 Agent for inhibiting symmetrical proteins, in particular enzymes |
| 10/07/1997 | US5674977 Branched synthetic peptide conjugate |
| 10/07/1997 | US5674976 Coupling first modular component to third modular component to yield precyclized gamma turn mimetic, cyclizing |
| 10/07/1997 | US5674898 Methods and therapeutic compositions for treating cystic fibrosis |
| 10/07/1997 | US5674855 Intravenously administering protein- and peptide-free mixture containing cholanic acid or salt and a phospholipid |
| 10/07/1997 | US5674848 Bioreactor compositions with enhanced cell binding |
| 10/07/1997 | US5674846 Having paralytic effect on larvae of tobacco budworm, heliothis virescens |
| 10/07/1997 | US5674844 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
| 10/07/1997 | US5674842 Growth inhibitory peptide |
| 10/07/1997 | US5674841 Method for inhibiting growth of stem cells |
| 10/07/1997 | US5674839 Cyclic analogs of alpha-MSH fragments |
| 10/07/1997 | US5674838 Cleavaged hirudin at amino acid position 36-37 or 63-64, linkaged with a polyether, amino compound or mono- or polysaccharides; anticoagulants |
| 10/07/1997 | US5674835 Papillomaviral expression inhibitors |
| 10/07/1997 | US5674834 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 10/07/1997 | US5674833 Detergent compositions containing protease and novel inhibitors for use therein |
| 10/07/1997 | US5674753 Epidermal growth factor receptor ectodomain |
| 10/07/1997 | US5674749 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-A, and uses thereof |
| 10/07/1997 | US5674748 Human cyclin-dependent kinase-like proteins and methods of using the same |
| 10/07/1997 | US5674746 DNA plasmids |
| 10/07/1997 | US5674739 Human gene FOHY030 coding for tumor progression inhibitor |
| 10/07/1997 | US5674736 Salmonella virulence genes |
| 10/07/1997 | US5674735 Isolated dna fragment encoding native equine herpes virus-4 glycoproteins (ehv-4 gh, gc); vaccines |
| 10/07/1997 | US5674734 Cell death protein |
| 10/07/1997 | US5674733 Method and materials for introducing DNA into Prevotella ruminicola |
| 10/07/1997 | US5674730 Eukaryotic cells comprising a DNA sequence encoding a bacterial-viral chimeric transactivator protein |
| 10/07/1997 | US5674724 Mutating the phoq gene to cause a gene under control of phop/phoq regulatort region to be expressed constitutively |
| 10/07/1997 | US5674720 Design and construction of non-infectious human retroviral mutants deficient in genomic RNA |
| 10/07/1997 | US5674712 Recombinant vector and use thereof for exocellular preparation of antibodies in single molecule form from Bacillus subtilis |
| 10/07/1997 | US5674711 Heteropolymeric protein production methods |
| 10/07/1997 | US5674710 Recombinant techniques for production of human brain natriuretic peptide |
| 10/07/1997 | US5674709 Pseudorabies virus protein |
| 10/07/1997 | US5674708 Amino acid at position 358 is selected from the group consisting of isoleucine, valine, alanine, aspartic acid, threonine and glutamic acid |
| 10/07/1997 | US5674706 Heterologous proteins produced by yeast transformed with an expression cassette using the alcohol dehydrogenase gene regulatory system |
| 10/07/1997 | US5674705 Isolating envelope gene, cleaving with restriction enzymes to generate envelope gene fragments, attaching polynucleotide linkers, inserting into expression vector, introducing vectors into prokaryotic cells |
| 10/07/1997 | US5674704 Polypeptide; human cell surface receptor |
| 10/07/1997 | US5674701 Administering an inhibitory amount of ethylene; screening for ethylene insensitivity; inoculating with pathogen; screening for disease tolerance |
| 10/07/1997 | US5674691 Method of screening for ligands to a receptor-type tyrosine kinase |
| 10/07/1997 | US5674689 Human calcitonin receptor polypeptides and methods of use |
| 10/07/1997 | US5674685 Systematic evolution of ligands bu exponential enrichment |
| 10/07/1997 | US5674681 Detecting association of a nonclassical major histocompatibility complex with a beta2 microglobin |
| 10/07/1997 | US5674676 HCV peptide antigens and method of determining HCV |
| 10/07/1997 | US5674503 Peptides capable of eliciting an immune response to leishmaniasis and methods of using the same |
| 10/07/1997 | US5674502 Cross-reactive influenza a immunization |
| 10/07/1997 | US5674500 Vaccines against Aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 10/07/1997 | US5674499 Equine herpesvirus gene 15 mutants |
| 10/07/1997 | US5674493 Compositions and methods for targeting cells with A2R and A2R monoclonal antibodies |
| 10/07/1997 | US5674492 Method of preventing or treating disease characterized by neoplastic cells expressing CD40 |
| 10/02/1997 | WO1997036179A1 Transcriptional regulatory sequences and uses thereof |
| 10/02/1997 | WO1997035997A2 Recombinant pox virus encoding myelin protein for therapy |
| 10/02/1997 | WO1997035996A1 Packaging cell line based on human 293 cells |
| 10/02/1997 | WO1997035995A1 Antitumour cellular compositions expressing at least three transgenes |
| 10/02/1997 | WO1997035991A1 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 10/02/1997 | WO1997035990A2 Histone deacetylases, and uses related thereto |
| 10/02/1997 | WO1997035985A1 Host cells expressing mutants of a natural g-protein coupled receptor (gpcr); saccharomyces cerevisiae ste2 gene, and their use as biosensors |
| 10/02/1997 | WO1997035984A1 Plant phosphate transporter gene and method of regulating plant growth with said gene |
| 10/02/1997 | WO1997035982A2 Monocyte chemotactic protein-5 materials and methods |
| 10/02/1997 | WO1997035981A1 Insect neuropeptides genes and peptides |
| 10/02/1997 | WO1997035979A1 Novel trio molecules and uses related thereto |
| 10/02/1997 | WO1997035978A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease |
| 10/02/1997 | WO1997035977A1 Polycation-sensing receptor in aquatic species and methods of use thereof |
| 10/02/1997 | WO1997035976A2 Epidermal differentiation factor |
| 10/02/1997 | WO1997035975A1 E2f-like transcription repressor and dna encoding it |
| 10/02/1997 | WO1997035974A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases |
| 10/02/1997 | WO1997035973A2 SEQUENCES CODING FOR CANINE β2- AND β3-ADRENERGIC RECEPTORS AND APPLICATIONS THEREOF AS PROBES AND FOR THE EXPRESSION OF PEPTIDES |
| 10/02/1997 | WO1997035972A1 Recombinant nucleic acid sequences coding for proteins with at least one hydrophobic domain, and uses thereof |
| 10/02/1997 | WO1997035971A1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES |
| 10/02/1997 | WO1997035969A2 Peptide ligands of the urokinase receptor |
| 10/02/1997 | WO1997035966A1 Methods and compositions for cellular and metabolic engineering |
| 10/02/1997 | WO1997035965A1 Plant sugar sensors and uses thereof |
| 10/02/1997 | WO1997035964A1 Fine magnetic particles containing useful proteins bound thereto, process for producing the same, and use thereof |
| 10/02/1997 | WO1997035963A1 Novel beta-2 adrenergic receptor subtype and use thereof |
| 10/02/1997 | WO1997035961A1 Ubiquitination of the transcription factor e2a |
| 10/02/1997 | WO1997035887A1 Precursors of catalytic antibodies |
| 10/02/1997 | WO1997035886A1 Surfaces which prevent or reduce complement activation |
| 10/02/1997 | WO1997035883A1 Method and apparatus for preparing an acellular red blood cell substitute |
| 10/02/1997 | WO1997035882A1 Lyophilized pulmonary surfactant peptide compositions |
| 10/02/1997 | WO1997035881A2 Receptor and transporter antagonists |
| 10/02/1997 | WO1997035880A2 Polynucleic acid sequences that are functionally associated with the development of autoimmune disease |
| 10/02/1997 | WO1997035879A1 Myelin oligodendrocyte glycoprotein peptides and uses thereof |
| 10/02/1997 | WO1997035878A2 The porcine heart fatty acid-binding protein encoding gene and methods to identify polymorphisms associated with body weight |
| 10/02/1997 | WO1997035877A1 Antibiotic peptides from bovine milk |
| 10/02/1997 | WO1997035875A1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient |
| 10/02/1997 | WO1997035873A2 Peptides with antiproliferative properties |
| 10/02/1997 | WO1997035872A1 CASPR/p190, A FUNCTIONAL LIGAND FOR RPTP-BETA AND THE AXONAL CELL RECOGNITION MOLECULE CONTACTIN |
| 10/02/1997 | WO1997035870A1 Growth factor htter36 |
| 10/02/1997 | WO1997035620A1 Formulations of ob protein |
| 10/02/1997 | WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen |
| 10/02/1997 | WO1997035612A1 Functional fragment antigen of tetanus toxin and tetanus vaccine |
| 10/02/1997 | WO1997035611A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof |
| 10/02/1997 | WO1997035610A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof |
| 10/02/1997 | WO1997035600A1 Glycosylated amylins |
| 10/02/1997 | WO1997035478A1 Selective target cell activation by expression of a g protein-coupled receptor activated superiorly by synthetic ligand |
| 10/02/1997 | WO1997031117A3 A human cytomegalovirus combined antigen and its use |
| 10/02/1997 | WO1997029201A3 Retroviral vector for the gene transfer of an il6 antagonist in human haematopoietic stem cells |
| 10/02/1997 | WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip) |
| 10/02/1997 | WO1997024111A3 Novel hyaluronic acid receptors binding agents and the use thereof |